2023-04-27 06:00:00 ET
You may have come into contact many times with McKesson (NYSE: MCK) without even realizing it. The healthcare company doesn't develop drugs, but it distributes a lot of the pharmaceutical products sold today. And in this behind-the-scenes role, McKesson has excelled.
The company has increased revenue over time and delivered gains in free cash flow. In fact, free cash flow has generally topped $4 billion in recent years. And this has helped McKesson invest wisely in its future.
The stock price performance has reflected this success. Over the past three years, McKesson stock has climbed nearly 160%. Could this top performer help you become a millionaire? Let's find out.
For further details see:
Could McKesson Stock Help You Become a Millionaire?